Back to Search
Start Over
Steven's Johnson syndrome with toxic epidermal necrolysis due to thalidomide in a case of multiple myeloma.
- Source :
-
Indian Journal of Pharmacology . Sep/Oct2014, Vol. 46 Issue 5, p557-559. 3p. - Publication Year :
- 2014
-
Abstract
- Thalidomide developed in 1954 for morning sickness had proven to be a teratogen and hence was withdrawn from market. Resurgence of thalidomide began as an immunomodulator when it was shown to be effective in the management of multiple myeloma and many conditions like erythema nodosum leprosum, graft versus host disease, recurrent aphthous ulcers etc. We report a case of Stevens Johnson syndrome-toxic epidermal necrolysis developing in an elderly male who was prescribed thalidomide after being diagnosed with multiple myeloma. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 02537613
- Volume :
- 46
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- Indian Journal of Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 98503028
- Full Text :
- https://doi.org/10.4103/0253-7613.140598